Inactive Instrument

Analyst Reco. APRIA

Equities

S&P Revises Owens & Minor Outlook To Stable From Positive On Acquisition Of Apria Health, Ratings Affirmed	22-01-11	MT
UBS Downgrades Apria to Neutral From Buy, Adjusts Price Target to $37.50 From $41	22-01-11	MT
Fitch Affirms OMI at 'BB-' Following Announced Plan to Buy Apria, Inc	22-01-11	AQ
Citigroup Reinstates Coverage of Apria at Buy with $43 Price Target	21-11-08	MT
UBS Adjusts Price Target on Apria to $41 From $37, Maintains Buy Rating	21-11-05	MT
APRIA : Citigroup Adjusts Apria's Price Target to $38 From $33, Maintains Buy Rating	21-08-06	MT
APRIA : Piper Sandler Adjusts Apria's Price Target to $35 From $33, Maintains Overweight Rating	21-08-06	MT
APRIA : Goldman Sachs Lowers Apria to Neutral From Buy, Price Target to $29 From $32	21-07-19	MT
APRIA : Citigroup Reinstates Apria at Buy With $33 Price Target	21-06-30	MT
APRIA : Citigroup Initiates Apria at Buy Rating With $33 Price Target	21-05-17	MT
APRIA : UBS Adjusts Apria's Price Target to $35 From $32, Maintains Buy Rating	21-05-14	MT
APRIA : Citigroup Adjusts Apria's Price Target to $30 From $26, Maintains Buy Rating	21-03-31	MT
APRIA : UBS Starts Apria at Buy With $26 Price Target	21-03-08	MT
APRIA : Citigroup Starts Apria at Buy with $26 Price Target	21-03-08	MT
APRIA : Piper Sandler Starts Apria at Overweight	21-03-08	MT
APRIA : Goldman Sachs Starts Apria at Buy With $30 Price Target	21-03-08	MT

No results for this search